ustekinumab biosimilars on BlueCross Rx Value (S5953-001)
Wezlana, Selarsdi, Pyzchiva and others
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 3 per 84 days.
$1,850.75
Patient pays / month, after deductible
$2,312.00
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
USTEKINUMAB 45 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $7,402.98 for a month. Other covered strengths are listed below.
Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| USTEKINUMAB 45 mg/.5mL Injection, Solution | 5 | $1,850.75 | PA · 3 per 84 days |
| USTEKINUMAB 45 mg/.5mL Injection, Solution | 5 | $2,244.91 | PA · 3 per 84 days |
| USTEKINUMAB 90 mg/mL Injection, Solution | 5 | $1,850.75 | PA · 3 per 84 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (888)645-6025. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5953-001